EN中
Press release
NEWS & EVENTS
ASGCT 2020 Abstract：Safety Evaluation of Intracerebral Injection of LentiviralABCD1 for X-ALD Gene Therapy
May 21st, 2020



  • © Shenzhen Genoimmune Medical Institute
    粤ICP备15092998号-1

  • Sitemap

    Our Institute
    Clinical Trials
    Our Science
    International Patients

  • Contact

    ADD: 35 Gatehouse Drive Waltham, MA 02451 United States
    TEL: 0755-86573763
    Email: gimi_trials@szgimi.org